AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Sacristan, JA Gomez, JC
Citation: Ja. Sacristan et Jc. Gomez, Olanzapine versus other antipsychotics in the treatment of schizophrenia -Reply, J CLIN PSY, 62(10), 2001, pp. 828-829

Authors: Galende, I Sacristan, JA
Citation: I. Galende et Ja. Sacristan, Compassionate use protocols and committees on ethics, MED CLIN, 116(15), 2001, pp. 599-599

Authors: Abad, F Calbo, F Zapater, P Rodriguez-Vilanova, F Garcia-Perez, LE Sacristan, JA
Citation: F. Abad et al., Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients, INT J ANT A, 15(1), 2000, pp. 65-71

Authors: Sacristan, JA Gilaberte, I Boto, B Buesching, DP Obenchain, RL Demitrack, M Sola, VP Alvarez, E Artigas, F
Citation: Ja. Sacristan et al., Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial, INT CLIN PS, 15(2), 2000, pp. 107-113

Authors: Sacristan, JA Kennedy-Martin, T Rosell, R Cardenal, F Anton, A Lomas, M Alberola, V Massuti, B Carrato, A Minshall, M
Citation: Ja. Sacristan et al., Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer, LUNG CANC, 28(2), 2000, pp. 97-107

Authors: Gomez, JC Sacristan, JA Hernandez, J Breier, A Carrasco, PR Saiz, CA Carbonell, EF
Citation: Jc. Gomez et al., The safety of olanzapine compared with other antipsychotic drugs: Results of an observational prospective study in patients with schizophrenia (EFESOstudy), J CLIN PSY, 61(5), 2000, pp. 335-343

Authors: Sacristan, JA Gomez, JC Montejo, AL Vieta, E Gregor, KJ
Citation: Ja. Sacristan et al., Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study, CLIN THER, 22(5), 2000, pp. 583-599

Authors: Sacristan, JA
Citation: Ja. Sacristan, Letters to the editor - Reply, CLIN THER, 22(11), 2000, pp. 1376-1376

Authors: Sacristan, JA Galende, I
Citation: Ja. Sacristan et I. Galende, Randomised database studies could serve as new strategy, BR MED J, 318(7191), 1999, pp. 1138-1138

Authors: Hylan, TR Meneades, L Crown, WH Sacristan, JA Gilaberte, I Montejo, AL
Citation: Tr. Hylan et al., SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study, J AFFECT D, 52(1-3), 1999, pp. 111-119

Authors: Sacristan, JA
Citation: Ja. Sacristan, Research in the trenches: a reflection on the naturalistic studies of medicines, MED CLIN, 113(16), 1999, pp. 613-615

Authors: Sacristan, JA
Citation: Ja. Sacristan, Medicine based evidence, MED CLIN, 112, 1999, pp. 9-11

Authors: Salvador-Carulla, L Haro, JM Cabases, J Madoz, V Sacristan, JA Vazquez-Barquero, JL
Citation: L. Salvador-carulla et al., Service utilization and costs of first-onset schizophrenia in two widely differing health service areas in North-East Spain, ACT PSYC SC, 100(5), 1999, pp. 335-343

Authors: Sacristan, JA Soto, J Galende, I
Citation: Ja. Sacristan et al., Evaluation of effectiveness by randomized assignment using data bases. Evidence based on medicine?, MED CLIN, 111(16), 1998, pp. 623-627
Risultati: 1-14 |